Search

everythinglearnresearchcommunity

for

Search:↓

Calcipotriol is the safest and most effective for hair regrowth in localized alopecia areata.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

Higher substance P levels may cause discomfort in hair loss patients.

Targeting DNA methylation can help treat skin disorders and cancers.

Interventional embolization is effective for treating scalp arteriovenous fistula but can cause complications like swelling and hair loss.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

PRP therapy is more effective than minoxidil for treating hair loss from androgenetic alopecia.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

The study aims to create a model to predict health attributes using diverse health data from Japanese adults.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The article concludes that PRP might help with hair loss, but more detailed research is necessary.

Dr. James Harris successfully incorporated Follicular Unit Extraction into his hair restoration practice, offering more surgical options and achieving natural results with the help of a team approach.

Androgenetic alopecia significantly affects mental health and quality of life, highlighting the need for psychiatric evaluations.

Two rare bald spots on the back of the scalp were found to be lupus, not alopecia areata.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Occipital scalp affects female hair loss; terminal/vellus ratio helps diagnose androgenetic alopecia.

Hair thickness decreases from the upper to lower areas of the back of the head, affecting hair transplant results.

Occipital donor sites for skin grafts heal faster, hurt less, look better, and have fewer complications than femoral sites.

Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.

The conclusion is that surgeons should carefully create a natural-looking occipital hairline in hair transplants to avoid detection.

A man's severe head pain after hair transplant was greatly relieved by pulsed radiofrequency treatment.

Thai males with hair loss have lower hair density in the occipital scalp compared to other Asians.

Epigenetic changes might protect occipital hair from male pattern baldness.

Hair in the front part of the scalp is more likely to fall out than hair in the back in acute telogen effluvium.

The belief about hair shedding phases is likely incorrect and needs reevaluation.

Severe male pattern hair loss is linked to lower hair density in the back of the head.

Females with pattern hair loss have more occipital involvement than males.

About one-third of Saudi women with female pattern hair loss also have thinning hair at the back of their head.